期刊
JOURNAL OF TISSUE ENGINEERING
卷 12, 期 -, 页码 -出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/20417314211000304
关键词
Tissue engineering; microvascular fragments; vascularization; erythropoietin; wound healing
资金
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [LA 2682/7-2]
- Saarland University
This study demonstrates that systemic low-dose erythropoietin (EPO) treatment can enhance the vascularization capacity and viability of adipose tissue-derived microvascular fragments (MVF).
Adipose tissue-derived microvascular fragments (MVF) are used as vascularization units in tissue engineering. In this study, we investigated whether the vascularization capacity of MVF can be improved by systemic low-dose erythropoietin (EPO) administration. MVF were isolated from the epididymal fat of donor mice and seeded onto collagen-glycosaminoglycan matrices, which were implanted into full-thickness skin defects within dorsal skinfold chambers of recipient mice. Both donor and recipient mice were treated daily with either EPO (500 IU/kg) or vehicle (0.9% NaCl). The implants were analyzed by stereomicroscopy, intravital fluorescence microscopy, histology, and immunohistochemistry. EPO-treated MVF contained a comparable number of proliferating Ki67(+) but less apoptotic cleaved caspase-3(+) endothelial cells when compared to vehicle-treated controls. Moreover, EPO treatment accelerated and improved the in vivo vascularization, blood vessel maturation, and epithelialization of MVF-seeded matrices. These findings indicate that systemic low-dose EPO treatment is suitable to enhance the viability and network-forming capacity of MVF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据